- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5375 - 1,4-Oxazines, e.g. morpholine
Patent holdings for IPC class A61K 31/5375
Total number of patents in this class: 1604
10-year publication summary
|
108
|
116
|
119
|
117
|
119
|
119
|
103
|
98
|
101
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 135 |
21 |
| Apnimed, Inc. (Delaware) | 52 |
21 |
| Bristol-myers Squibb Company | 4872 |
18 |
| Axsome Therapeutics, Inc. | 248 |
18 |
| Novartis AG | 10882 |
17 |
| Allergan, Inc. | 2361 |
15 |
| Aeromics, Inc. | 29 |
13 |
| Arbor Pharmaceuticals, LLC | 69 |
11 |
| Epizyme, Inc. | 370 |
11 |
| vTv Therapeutics LLC | 152 |
11 |
| The Regents of the University of California | 19859 |
10 |
| Boehringer Ingelheim International GmbH | 4705 |
10 |
| Centre National de La Recherche Scientifique | 10395 |
10 |
| Gilead Sciences, Inc. | 2032 |
10 |
| Global Blood Therapeutics, Inc. | 183 |
10 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
10 |
| F. Hoffmann-La Roche AG | 7932 |
9 |
| Astellas Pharma Inc. | 1088 |
9 |
| The Cleveland Clinic Foundation | 1575 |
9 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2791 |
9 |
| Other owners | 1352 |